Loading...

Advanced Exoskeleton Devices Will Broaden Rehabilitation Market Access

Published
01 May 25
Updated
10 Aug 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-60.1%
7D
-3.9%

Author's Valuation

US$6.7533.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 10 Aug 25

Fair value Decreased 81%

The drastic reduction in Ekso Bionics Holdings' consensus price target from $34.75 to $6.75 reflects sharply lower growth and earnings expectations as seen in the substantial drop in its forward P/E multiple from 24.94x to 4.86x. What's in the News Launched eksoUniversity, an online platform offering CEU-approved courses for physical therapists and assistants in over 30 states.

Shared on 01 Aug 25

Fair value Decreased 7.33%

Despite sharply improved consensus revenue growth forecasts, a significant rise in the company's future P/E multiple has driven analysts to lower Ekso Bionics Holdings' fair value estimate from $37.50 to $34.75. What's in the News Launched eksoUniversity, an online continuing education platform for physical therapists, offering courses approved for CEUs in over 30 states.